Recruiting NA Primary Progressive Aphasia

New treatment option for Primary Progressive Aphasia

Official title Stimulating the Aging Brain Using Brain and Sensory Stimulation

ClinicalTrials.gov ID: NCT07650188

What this study is testing

What it's testing
The goal of this project is to investigate whether transcranial electrical stimulation and sensory stimulation affect language outcomes in individuals with primary progressive aphasia (PPA). The main questions it aims to answer are: Does transcranial alternating current stimulation (tACS) affect verbal short-term memory (STM) in individuals with PPA?

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 45 and older

You may be able to join if

  • Clinical exam supports diagnosis of PPA and/or MCI with no report of difficulty functioning in basic or instrumental activities of daily living.
  • Completed clinical cognitive exam within 6 months of study baseline visit OR neuropsychological research battery within 6 months of study baseline...

You likely can't join if

  • Evidence of dementia at baseline
  • Known history of neoplasm, symptomatic stroke, moderate to severe traumatic brain injury, or other significant neurologic event
  • Age \<45 years.
  • Evidence of severe psychiatric illness (e.g., bipolar disorder, schizophrenia).
  • Presence of cardiac stimulators or pacemakers
  • Any other implants near the scalp or in the eye
See the full eligibility criteria
Who can join
  • Clinical exam supports diagnosis of PPA and/or MCI with no report of difficulty functioning in basic or instrumental activities of daily living.
  • Completed clinical cognitive exam within 6 months of study baseline visit OR neuropsychological research battery within 6 months of study baseline visit.
What rules you out
  • Evidence of dementia at baseline
  • Known history of neoplasm, symptomatic stroke, moderate to severe traumatic brain injury, or other significant neurologic event
  • Age \<45 years.
  • Evidence of severe psychiatric illness (e.g., bipolar disorder, schizophrenia).
  • Presence of cardiac stimulators or pacemakers
  • Any other implants near the scalp or in the eye
  • Contraindications to MRI or stimulation
  • Pregnancy
  • History of ongoing or unmanaged seizures
  • History of dyslexia or other developmental learning disabilities

The study team makes the final eligibility decision.

Where it's taking place

  • Milwaukee, Wisconsin, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 45 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Milwaukee, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.